and interest Objectives To be used for working capital (4) Nature of relationship The Company holds 70% of the share in the Company’s subsidiary, KT Medical Service Company Limited and the details of
share of THB 0. 13, comparing to a net profit of THB 24. 02 million or earnings per share of THB 0. 02 during the second quarter last year, an increase of THB 102.42 million or 426.44%. Details were as
its subsidiaries (the “Company”) has recently submitted the reviewed interim financial statements for the period ended 30 September 2017 to the Stock Exchange of Thailand with a view to share the
2017 to Baht 1,842 million in 2018, primarily due to commercial operation of new plants and an improvement on financing cost mainly attributable to debt refinancing after issuing project bond in May 2018
% 1.43 2.6% SG&A 23.15 17.6% 20.92 15.8% (2.23) (9.6%) EBIT 33.30 25.3% 38.21 28.8% 4.92 14.8% Share of Loss in Associates - 0.40 0.3% 0.40 Interest Expenses 0.14 0.1% 0.14 0.1% (0.01) (4.9%) EBT 33.16
% 20.31 10.66 90% EBITDA * 108.36 86.81 25% 248.65 182.99 36% % EBITDA * 26% 23% 3% 29% 24% 5% Other income /(expenses) 5.56 4.72 18% 110.34 14.20 677% Financing cost 1.22 4.32 -72% 3.83 4.62 -17% Corporate
% 126.54 46.2% 16.62 15.1% SG&A 35.95 14.1% 48.13 17.6% 12.18 33.9% EBIT 73.97 29.1% 78.41 28.6% 4.44 6.0% Share of Gain in Associates - - 0.15 0.1% 0.15 Interest Expenses 0.29 0.1% 0.25 0.1% (0.04) (13.8
, purchasing power is still weak and no clear sign of recovery in sight. To strengthening their competitive edge in other to enlarge market share, the players have to focus on boosting sales figures rather than
30.84 -1.87 -6% Finance cost -5.33 -5.87 -0.54 -9% Income tax expenses -4.36 -6.68 -2.32 -35% Net income for period 19.28 18.30 0.98 5% Earnings per share (THB) 0.06 0.06 0.00 5% Golden Lime Public